Rockwell Medical, Inc. to Discuss Second Quarter 2019 Financial Results on August 8, 2019
July 29 2019 - 4:30PM
Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”)
(Nasdaq: RMTI) today announced that the Company will release its
2019 second quarter financial results on Thursday, August 8, 2019,
after the close of the U.S. financial markets.
Stuart Paul, Chief Executive Officer, and Angus Smith, Chief
Financial Officer, will host a conference call to discuss the
results as follows:
Date Time Toll free (U.S.)
International Webcast (live and replay) |
Thursday, August 8, 2019 4:30 p.m. EDT(877) 383-7438(678)
894-3975www.rockwellmed.com under the “Investor” section |
The webcast will be archived for 30 days at the aforementioned
URL.
About Rockwell Medical, Inc.Rockwell Medical is
a biopharmaceutical company targeting end-stage renal disease
(ESRD) and chronic kidney disease (CKD). Rockwell Medical's
exclusive renal drug therapies support disease management
initiatives to improve the quality of life and care of dialysis
patients and are intended to deliver safe and effective therapy,
while decreasing drug administration costs and improving patient
convenience. Rockwell Medical's anemia drug Triferic is the only
FDA-approved product indicated for iron replacement and maintenance
of hemoglobin in hemodialysis patients. Rockwell's FDA approved
generic drug Calcitriol (active vitamin D) is for treating
secondary hyperparathyroidism in patients undergoing chronic renal
dialysis. Rockwell Medical is also an established manufacturer,
supplier and leader in delivering high-quality hemodialysis
concentrates/dialysates (used to maintain human life by removing
toxins and replacing critical nutrients in the dialysis patient's
bloodstream) to dialysis providers and distributors in the U.S. and
abroad. Please visit www.rockwellmed.com for more information.
Contact:Investor Relations for Rockwell
Medical, Inc.: Lisa M. WilsonT: 212-452-2793E:
lwilson@insitecony.com
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Sep 2023 to Sep 2024